Get the Stockscreener App
5.69
1.07%
0.06
Immatics N V stock is traded at $5.69, with a volume of 302.23K.
It is up +1.07% in the last 24 hours and down -4.21% over the past month.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
See More
Previous Close:
$5.63
Open:
$5.63
24h Volume:
302.23K
Relative Volume:
0.49
Market Cap:
$691.62M
Revenue:
$58.49M
Net Income/Loss:
$-105.04M
P/E Ratio:
-4.3779
EPS:
-1.2997
Net Cash Flow:
$-13.78M
1W Performance:
-10.11%
1M Performance:
-4.21%
6M Performance:
+23.70%
1Y Performance:
-49.24%
1-Day Range:
$5.60
$5.7926
1-Week Range:
$5.42
$6.4725
52-Week Range:
$3.30
$13.09
Immatics N V Stock (IMTX) Company Profile
Compare IMTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
5.69 | 754.88M | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Initiated | Deutsche Bank | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
Multi Factor Analysis Ranks Immatics N.V. Equity Warrant as Strong Buy2025 Institutional Moves & Safe Entry Point Alerts - newsyoung.net
Immatics N.V. Reports Q2 2025 Financial Results - TipRanks
Pattern recognition hints at Immatics N.V. Equity Warrant upsideJuly 2025 Gainers & Technical Entry and Exit Tips - Newser
What machine learning models say about Immatics N.V.Quarterly Profit Report & Weekly Watchlist for Consistent Profits - Newser
How to use Fibonacci retracement on Immatics N.V.Weekly Loss Report & Technical Analysis for Trade Confirmation - Newser
Analysts Offer Insights on Healthcare Companies: Immatics (IMTX) and Insight Molecular Diagnostics (IMDX) - The Globe and Mail
Smart tools for monitoring Immatics N.V. Equity Warrant’s price actionProfit Target & Safe Capital Growth Plans - Newser
Using Ichimoku Cloud for Immatics N.V. Equity Warrant technicalsJuly 2025 Action & Risk Managed Trade Strategies - Newser
Tools to monitor Immatics N.V. recovery probabilityJuly 2025 Drop Watch & Reliable Price Breakout Alerts - Newser
Will earnings trigger a reversal in Immatics N.V. Equity Warrant2025 Key Highlights & Low Risk Investment Opportunities - Newser
Will Immatics N.V. Equity Warrant continue its uptrendWeekly Stock Report & Safe Swing Trade Setups - Newser
Market reaction to Immatics N.V. Equity Warrant’s recent news2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Custom strategy builders for tracking Immatics N.V. Equity WarrantWeekly Market Outlook & Accurate Intraday Trade Tips - Newser
Mizuho reiterates Outperform rating on Immatics stock following Q2 results - Investing.com
What analysts say about Immatics N.V. stockJuly 2025 Earnings & Growth Focused Entry Reports - thegnnews.com
Immatics N.V. (NASDAQ:IMTX) Analysts Just Slashed This Year's Estimates - Yahoo Finance
Can swing trading help recover from Immatics N.V. lossesWeekly Profit Report & Verified Technical Trade Signals - Newser
Visualizing Immatics N.V. stock with heatmaps2025 Retail Activity & High Accuracy Swing Entry Alerts - Newser
Tick level data insight on Immatics N.V. volatilityJuly 2025 Trade Ideas & Daily Technical Forecast Reports - Newser
Using economic indicators to assess Immatics N.V. Equity Warrant potentialWeekly Profit Analysis & Low Risk Profit Maximizing Plans - Newser
Is Immatics N.V. Equity Warrant stock ready for a breakoutJuly 2025 Outlook & Intraday High Probability Setup Alerts - Newser
How to manage a losing position in Immatics N.V.GDP Growth & Real-Time Buy Zone Alerts - Newser
Immatics N.V. Added to Custom Quant Screener TodayWeekly Investment Recap & Free Expert Approved Momentum Trade Ideas - 선데이타임즈
Evaluating Immatics N.V. with trendline analysis2025 Sector Review & Low Risk High Win Rate Picks - Newser
What Fibonacci levels say about Immatics N.V. Equity Warrant rebound2025 Historical Comparison & AI Powered Buy and Sell Recommendations - Newser
News impact scoring models applied to Immatics N.V. Equity WarrantDollar Strength & Reliable Intraday Trade Alerts - Newser
Immatics (IMTX) Maintains Buy Rating from Leerink Partners - AInvest
Is Immatics N.V.’s ROE strong enough2025 Volume Leaders & Weekly Watchlist for Hot Stocks - thegnnews.com
Advanced analytics toolkit walkthrough for Immatics N.V. Equity WarrantJuly 2025 Gainers & Weekly Sector Rotation Insights - Newser
Is Immatics N.V. Equity Warrant showing signs of accumulationJuly 2025 Big Picture & Community Consensus Trade Signals - Newser
Immatics N.V. Equity Warrant Moves Into Bullish Territory Based on MACDEarnings Growth Summary & Weekly Watchlist of Top Performers - 선데이타임즈
Immatics N.V. Equity Warrant stock trend outlook and recovery pathMarket Activity Summary & Daily Technical Stock Forecast Reports - Newser
Key metrics from Immatics N.V. Equity Warrant’s quarterly dataLayoff News & Safe Entry Zone Tips - Newser
Using portfolio simulators with Immatics N.V. Equity Warrant includedEarnings Miss & Free Reliable Trade Execution Plans - Newser
What the charts say about Immatics N.V. today2025 Investor Takeaways & Real-Time Sentiment Analysis - Newser
Is Immatics N.V. exposed to political riskWeekly Market Outlook & Daily Momentum Trading Reports - thegnnews.com
Does Immatics N.V. Equity Warrant qualify in momentum factor screeningWeekly Loss Report & Weekly Breakout Stock Alerts - Newser
Using flow based indicators on Immatics N.V.July 2025 Selloffs & Verified Momentum Stock Ideas - Newser
Is Immatics N.V. stock a value trap2025 Pullback Review & High Return Trade Opportunity Guides - newsimpact.co.kr
Immatics N.V. Equity Warrant stock daily chart insightsEarnings Miss & Fast Gain Stock Trading Tips - Newser
Comparing Immatics N.V. Equity Warrant in custom built stock radarsBuy Signal & Accurate Entry and Exit Point Alerts - Newser
Immatics reports Q2 EPS (EUR 0.58) vs (EUR 0.17) last year - MSN
Trapped Investors in Immatics N.V. Await Breakout Signal2025 Trading Recap & AI Forecast Swing Trade Picks - newsyoung.net
Immatics N.V. Equity Warrant Stock Support and Resistance Levels You Should KnowJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - Newser
Immatics: Q2 Earnings Snapshot - Greenwich Time
Immatics N.V. Recovery Linked to Earnings Surprise2025 Macro Impact & Real-Time Volume Surge Alerts - newsyoung.net
What makes Immatics N.V. Equity Warrant stock price move sharplyFed Meeting & Growth Focused Stock Pick Reports - Newser
Detecting support and resistance levels for Immatics N.V.July 2025 Drop Watch & Fast Entry High Yield Stock Tips - Newser
Using Ichimoku Cloud for Immatics N.V. technicalsMarket Volume Report & Free Low Drawdown Momentum Trade Ideas - Newser
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):